# OnCo record bcg-intravesical (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bcg-intravesical/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bcg-intravesical" ;
  schema:name "Intravesical BCG"@en ;
  schema:description "A weakened tuberculosis vaccine put directly into the bladder. Since 1976 it has been the most effective treatment for early bladder cancer, and it remains in chronic short supply."@en ;
  schema:url <https://onco.cc/drugs/bcg-intravesical/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/BCG_vaccine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q798309> ;
  schema:citation <https://en.wikipedia.org/wiki/BCG_vaccine> ;
  onco:status "standard-of-care" ;
  onco:modality "Live bacterial immunotherapy (intravesical)" ;
  schema:alternateName "TICE BCG" ;
  onco:approval "US 1990: Carcinoma in situ of the bladder (TICE BCG)" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/bcg-and-intravesical-therapy/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:terms <https://onco.cc/terms/nmibc-vs-mibc/>, <https://onco.cc/terms/bcg-unresponsive/> ;
  onco:trials <https://onco.cc/trials/potomac/>, <https://onco.cc/trials/quilt-3-032/> .